Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol in Stage III-IV Chronic Kidney Disease
NCT01136564Phase 2Completed
- Start
- Jul 2010
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) comparing Paricalcitol with Placebo (2 arms). Primary endpoint: Plasma renin concentration at 6 weeks. Started Jul 2010; status: completed.
02
Drugs
paricalcitol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01136564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01136564.